Why has the Ebola virus suddenly erupted in a region of Africa known as the meningitis Belt? The recent Ebola outbreak in Africa coincides with a massive Meningitis Vaccine campaign targeting “150 million Africans”, many throughout Guinea & Nigeria. The cost-effective vaccine, MenAfriVac®, (less than US$0.50 per dose) was “kept outside the cold chain for up to four days at up to 40°C”. Neighboring Liberia & Sierra Leone, both primary epicenters, were recently subject to the “largest ever Yellow Fever Immunization Program” conducted in that region – an estimated 12 million locals impacted (infected) by the compound shot. Vaccine Resistance Movement is investigating the link between these extremely toxic experimental vaccines and the sudden surge in cases of Ebola. Symptoms of ‘Acute fulminating Meningococcal Septicemia’, a virulent form of bacterial meningitis (marked by extreme vomiting, hemorrhaging – excessive bleeding around the eyes & mouth, severe blackish bruising on the arms & legs), leading to Septic shock and potentially even death, closely resemble those seen in Ebola victims. This supposed outbreak of Ebola bares all the hallmarks of a rarified, virulent strain of bacterial Meningitis, ‘Acute fulminating Meningococcal Septicemia’, also known as ‘Waterhouse-Friderichsen Syndrome’. vaccineresistancemovement.org/?page_id=11240
Posted on: Wed, 22 Oct 2014 01:04:31 +0000
Trending Topics
Recently Viewed Topics
© 2015